Bristol Myers Squibb Company SCA
About
We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.
Each day, our employees around the world work together for patients—it drives everything we do. We are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience, and fibrosis. Through our Research & Development organization, we have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate our work.
Address
6 Rue Jean Monnet
2180 Luxembourg
Contact details
Medical Information phone number
+32 2 352 7611
Medical Information website
Bristol-Myers Squibb Medical Information Online for Luxemburg
Medical Information email
medicalinfo.belgium@bms.com
Adverse events and product complaints
Signalez des effets secondaires/indésirables ou des plaintes à propos de la qualité d'un produit. Contactez nous par:
Rapporteer bijwerkingen/nadelige reacties of klachten over de productkwaliteit
Contacteer ons via:
Meldung eines unerwünschten Ereignisses / Produktbeanstandung. Sie bitte:
Adverse event phone number
+32 2 352 7611
Adverse event email
medicalinfo.belgium@bms.com
BMS products
Medicinal products marked with▼are subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.
Abraxane®
(nab-paclitaxel)
Azactam®
(aztreonam)
Baraclude®
(entecavir)
Camzyos® ▼
(mavacamten)
Eliquis® (Co-Promoted Pfizer)
(apixaban)
Empliciti®
(elotuzumab)
Imnovid® ▼
(pomalidomide)
Inrebic® ▼
(fedratinib)
Kenacort-A10®
(triamcinolone acetonide)
Opdivo®
(nivolumab)
Opdualag® ▼
(nivolumab + relatlimab)
Orencia®
(abatacept)
Reblozyl® ▼
(luspatercept)
Revlimid® ▼
(lenalidomide)
Sotyktu® ▼
(deucravacitinib)
Sprycel®
(dasatinib)
Thalidomide BMS
(thalidomide)
Vidaza®
(azacitidine)
Yervoy®
(ipilimumab)
Zeposia® ▼
(ozanimod)
